PT Ikapharmindo Putramas Tbk (IDX:IKPM)
Indonesia · Delayed Price · Currency is IDR 194.00
0.00 (0.00%)
Last updated: Sep 2, 2026, 11:51 AM WIB
IDX:IKPM Revenue
PT Ikapharmindo Putramas Tbk had revenue of 108.29B IDR in the quarter ending June 30, 2026, with 27.19% growth. This brings the company's revenue in the last twelve months to 400.25B, up 2.03% year-over-year. In the year 2025, PT Ikapharmindo Putramas Tbk had annual revenue of 363.57B, down -11.77%.
Revenue (ttm)
400.25B
Revenue Growth
+2.03%
P/S Ratio
0.82
Revenue / Employee
390.11M
Employees
1,026
Market Cap
326.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 363.57B | -48.50B | -11.77% |
| Dec 31, 2024 | 412.07B | -29.07B | -6.59% |
| Dec 31, 2023 | 441.14B | 42.40B | 10.63% |
| Dec 31, 2022 | 398.73B | 17.82B | 4.68% |
| Dec 31, 2021 | 380.92B | -334.88B | -46.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 37.72T |
| PT Siloam International Hospitals Tbk | 13.51T |
| PT Mitra Keluarga Karyasehat Tbk | 5.57T |
| PT Millennium Pharmacon International Tbk | 4.30T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.70T |
| PT Phapros Tbk | 961.30B |
| PT Royal Prima Tbk | 320.78B |
| PT Diagnos Laboratorium Utama Tbk | 176.49B |